Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03400176
Title VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego - Moores Cancer Center La Jolla California 92093-0658 United States Details
David Geffen School of Medicine at UCLA David Geffen School of Med Los Angeles California 90095 United States Details
Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State University Columbus Ohio 43210 United States Details
Tennessee Oncology Centennial Medical Center Nashville Tennessee 37203 United States Details
University of Utah / Huntsman Cancer Institute Oncology Salt Lake City Utah 84103 United States Details
*Shaded cells indicate that there was no data available from for the field